S&P 500 Futures
(0.05%) 5 524.25 points
Dow Jones Futures
(0.17%) 39 537 points
Nasdaq Futures
(-0.04%) 19 919 points
Oil
(0.67%) $82.09
Gas
(-0.81%) $2.58
Gold
(-0.05%) $2 338.40
Silver
(1.00%) $29.53
Platinum
(-0.61%) $995.80
USD/EUR
(-0.42%) $0.929
USD/NOK
(-0.43%) $10.63
USD/GBP
(-0.21%) $0.789
USD/RUB
(1.78%) $87.25

Echtzeitaktualisierungen für Sarepta Therapeutics, [0L35.L]

Börse: London Stock Exchange Sektor: Healthcare Industrie: Medical - Pharmaceuticals
Zuletzt aktualisiert28 Jun 2024 @ 19:55

1.37% $ 158.65

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 19:55):
Our systems believe the stock currently is overvalued by -1.25% compare to its pairs and should correct downwards.
Profile picture for Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases...

Stats
Tagesvolumen 351
Durchschnittsvolumen 424
Marktkapitalisierung 15.00B
EPS $0.380 ( Q1 | 2024-05-01 )
Nächstes Ertragsdatum ( $0 ) 2024-07-30
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -37.02
(Sector) 0
(Industry) 0
ATR14 $1.006 (0.64%)